AQR Capital Management - SUCAMPO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$715,000
-53.8%
60,610
-58.9%
0.00%
-50.0%
Q2 2017$1,549,000
+27.8%
147,538
+34.0%
0.00%0.0%
Q1 2017$1,212,000
+85.6%
110,141
+128.7%
0.00%
+100.0%
Q4 2016$653,000
-29.7%
48,170
-36.2%
0.00%0.0%
Q3 2016$929,000
-20.9%
75,449
-29.5%
0.00%
-50.0%
Q2 2016$1,175,000
-55.0%
107,079
-55.2%
0.00%
-60.0%
Q1 2016$2,614,000
-56.7%
239,219
-31.5%
0.01%
-54.5%
Q4 2015$6,039,000
+36.7%
349,304
+57.1%
0.01%
+22.2%
Q3 2015$4,418,000
-1.7%
222,319
-18.7%
0.01%0.0%
Q2 2015$4,495,000
+191.3%
273,575
+175.8%
0.01%
+125.0%
Q1 2015$1,543,000
+1715.3%
99,186
+663.0%
0.00%
Q3 2014$85,000
-5.6%
13,0000.0%0.00%
Q2 2014$90,000
-30.2%
13,000
-28.2%
0.00%
Q1 2014$129,00018,1000.00%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 2,803,138$30,835,0009.94%
Redwood Investments, LLC 603,176$6,635,0000.66%
ALGERT GLOBAL LLC 205,529$2,261,0000.61%
Nine Chapters Capital Management LLC 40,500$446,0000.60%
Malaga Cove Capital, LLC 84,269$897,0000.54%
CLARK ESTATES INC/NY 250,000$2,750,0000.42%
AlphaMark Advisors, LLC 78,500$864,0000.40%
Ativo Capital Management LLC 109,023$1,199,0000.30%
GLOBEFLEX CAPITAL L P 103,949$1,143,0000.27%
Piermont Capital Management Inc. 65,959$726,0000.17%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders